HI EVERYONE, it is with some interest to follow your opinion and thoughts, and on this occasion I would like to share with you my point of view.
Assuming expected earnings -"We are very clear in that it is earnings not revenue.":
- expected to be $3mil, taking under consideration only one activity x say 15 = $45,000,000 P/A
- number of shares with full subscription - 9,801,032,786
- so based on my very simple calculation - $45m / number of shares = $0.004. Of course it is not $0.02, but better than $0.001
If the above calculation is correct, then everyone, ECT and its shareholders are better off for number of reason, assuming that our Management is committed to its direction / promises to be executed with expected level of professionalism and integrity.
Revenue is the income generated before expenses are deducted. Revenue is also called net sales for some companies since net sales include any returns of merchandise by customers.
Earnings, by contrast, reflect the bottom line on the income statement and is the profit a company has earned for a period.
AIMO
- Forums
- ASX - By Stock
- ECT - Q&A Session - India Update
HI EVERYONE, it is with some interest to follow your opinion and...
-
- There are more pages in this discussion • 90 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add ECT (ASX) to my watchlist
(20min delay)
|
|||||
Last
0.2¢ |
Change
0.000(0.00%) |
Mkt cap ! $6.343M |
Open | High | Low | Value | Volume |
0.0¢ | 0.0¢ | 0.0¢ | $0 | 0 |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
13 | 4003629 | 0.2¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
0.3¢ | 15249389 | 23 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
13 | 4003629 | 0.002 |
27 | 35956532 | 0.001 |
0 | 0 | 0.000 |
0 | 0 | 0.000 |
0 | 0 | 0.000 |
Price($) | Vol. | No. |
---|---|---|
0.003 | 15249389 | 23 |
0.004 | 7303519 | 10 |
0.005 | 3296859 | 21 |
0.006 | 3178567 | 7 |
0.007 | 918333 | 2 |
Last trade - 16.12pm 13/11/2024 (20 minute delay) ? |
Featured News
ECT (ASX) Chart |
Day chart unavailable
The Watchlist
NUZ
NEURIZON THERAPEUTICS LIMITED
Michael Thurn, CEO & MD
Michael Thurn
CEO & MD
SPONSORED BY The Market Online